DrugPatentWatch Database Preview
Drugs in Development Information for Oteracil
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Oteracil?
Oteracil is an investigational drug.
There have been 66 clinical trials for Oteracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Stomach Neoplasms, Pancreatic Neoplasms, and Carcinoma. The leading clinical trial sponsors are Fudan University, Taiho Oncology, Inc., and Quintiles, Inc.
There are eighty-six US patents protecting this investigational drug and eight hundred and twenty international patents.
Summary for Oteracil
| US Patents | 86 |
| International Patents | 820 |
| US Patent Applications | 128 |
| WIPO Patent Applications | 80 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2016-09-01) |
| Vendors | 27 |
Recent Clinical Trials for Oteracil
| Title | Sponsor | Phase |
|---|---|---|
| Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma | RenJi Hospital | Phase 2 |
| A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | Shanghai Henlius Biotech | Phase 3 |
| SOX-based CRT for Esophageal Cancer. | Zhejiang Provincial People’s Hospital | Phase 1/Phase 2 |
Clinical Trial Summary for Oteracil
Top disease conditions for Oteracil
Top clinical trial sponsors for Oteracil
US Patents for Oteracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Oteracil | Start Trial | Chromane herbicides | E. I. Du Pont de Nemours and Company (Wilmington, DE) | Start Trial |
| Oteracil | Start Trial | Composition and method for inhibiting inflammation caused by non-parenteral administration of 5-fluorouracil type compounds | Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP) | Start Trial |
| Oteracil | Start Trial | Salts of optically active 4-hydroxy-8(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo(1,5-A)-1,3,5- triazines and a process for production thereof | Otsuka Pharmaceutical Factory, Inc. (Tokushima, JP) | Start Trial |
| Oteracil | Start Trial | Prodrugs for selective drug delivery | Start Trial | |
| Oteracil | Start Trial | Enzyme assay of biochemical substances | Oriental Yeast Co., Ltd. (Tokyo, JP) | Start Trial |
| Oteracil | Start Trial | Compositions, methods and kits for potentiating antitumor effect and for treating tumor | Taiho Pharmaceutical Co., Ltd. (Tokyo, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Oteracil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Oteracil | Argentina | 243522 | 2006-12-10 | Start Trial |
| Oteracil | Australia | 8215287 | 2006-12-10 | Start Trial |
| Oteracil | Brazil | 8706588 | 2006-12-10 | Start Trial |
| Oteracil | China | 1021824 | 2006-12-10 | Start Trial |
| Oteracil | China | 87107276 | 2006-12-10 | Start Trial |
| Oteracil | German Democratic Republic | 270532 | 2006-12-10 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
